Tumori Journal, Год журнала: 2023, Номер 110(1), С. 74 - 76
Опубликована: Окт. 30, 2023
Язык: Английский
Tumori Journal, Год журнала: 2023, Номер 110(1), С. 60 - 68
Опубликована: Авг. 10, 2023
Background: Patients with cancer present a higher risk of vaccine-preventable diseases. Recommended vaccinations are the most cost-effective measure to reduce transmission and related complications. Nevertheless, vaccination rates inadequate. Oncologists have central role in tailored vaccine communication their patients. We results survey conducted by AIOM 2022, focusing on perception problem oncologists. Materials Methods: An anonymous 31-item online questionnaire was shared 15 September 2022 website. The objectives this were examine Italian oncologists diseases main available vaccines, attitude towards recommending vaccines COVID-19 pandemic impact habits regarding Results: Between January 2023, 114 medical (5% members) completed questionnaire. At first oncological visit, only 30% respondents usually propose schedule all patient, 41% do not discuss at visit 29% recommend exclusively specific categories For 56% respondents, patients more aware benefits whereas 36% reported that worried receiving too many vaccines. Conclusion: This is among better understand attitudes vaccination. It highlights urgent issues educating training awareness need build (or implement) network multidisciplinary collaborations.
Язык: Английский
Процитировано
13
JCO Oncology Practice, Год журнала: 2025, Номер unknown
Опубликована: Фев. 20, 2025
Patients with solid tumors present a higher risk of infectious diseases worse outcomes compared immunocompetent patients. Prolonged treatment prophylactic and empirically chosen antibiotics health care-acquired infections can predispose patients cancer to antimicrobial-resistant (AMR) organisms. AMR is global priority affect cancer. The outcome worsens dramatically if multidrug-resistant (MDR) microorganisms cause infections. Moreover, the emergence MDR organisms increases care costs. Antimicrobial stewardship programs be useful monitor improve use in all oncological settings, including palliative setting. Awareness magnitude these issues still low, so it important inform educate oncologists. This narrative review aims illustrate main evidence on caused by tools that oncologists should have enhance their multidisciplinary management.
Язык: Английский
Процитировано
0
Cochrane library, Год журнала: 2025, Номер 2025(4)
Опубликована: Апрель 16, 2025
Язык: Английский
Процитировано
0
Journal of Endocrinological Investigation, Год журнала: 2025, Номер unknown
Опубликована: Апрель 23, 2025
Язык: Английский
Процитировано
0
Vaccines, Год журнала: 2023, Номер 11(5), С. 911 - 911
Опубликована: Апрель 28, 2023
At the time when mass COVID-19 vaccination began, providing appropriate advice to uro-oncology patients became a challenge. This was single-center cross-sectional observational study aimed investigate rate of among receiving systemic therapy for metastatic renal cell carcinoma and castration-resistant prostate cancer. Furthermore, we assess patients' attitudes identify factors influencing their decision vaccinate against COVID-19. Data on sociodemographic characteristics, status, awareness about were collected from questionnaires completed by patients. A total 173 enrolled in this study, 124 (71.7%) them vaccination. Significantly higher rates found male patients, also older highly educated those who lived with one household member. significantly had consulted doctors involved treatment, particularly urologists. significant association observed between doctor's advice, family member influence, personal beliefs toward Our showed multiple associations characteristics rates. consultation are oncology treatment received associated
Язык: Английский
Процитировано
4
Vaccines, Год журнала: 2024, Номер 12(6), С. 642 - 642
Опубликована: Июнь 8, 2024
In patients with cancer, tumor- and treatment-induced immunosuppression are responsible for a four-fold increase in morbidity mortality caused by influenza invasive Streptococcus pneumoniae infections compared to the general population. The main oncology societies strongly recommend vaccination cancer prevent these infections. However, vaccine hesitancy is concern this aim of study was assess feasibility in-hospital under anticancer treatment their family members (FMs) against pneumococcal during COVID-19 pandemic order coverage. This single-center, prospective, observational conducted at Department Oncology Luigi Sacco University Hospital (Milan, Italy) between October 2020 April 2021. primary outcome incidence influenza-like illness (ILI) secondary safety. A total 341 subjects were enrolled, including 194 147 FMs. ILI higher among than FMs (9% vs. 2.7%, OR 3.92, p = 0.02). Moreover, two diagnosed pneumonia. most frequent vaccine-related AEs pain injection site (31%) fatigue (8.7%). conclusion, hospital-based strategy feasible pandemic, representing potential model maximize coverage public health emergency.
Язык: Английский
Процитировано
1
Future Oncology, Год журнала: 2024, Номер 20(21), С. 1451 - 1454
Опубликована: Май 28, 2024
Язык: Английский
Процитировано
1
ACS Applied Materials & Interfaces, Год журнала: 2024, Номер 16(44), С. 60045 - 60055
Опубликована: Окт. 25, 2024
Respiratory viruses ravage the world and seriously threaten people's health. Despite intense research efforts, immune mechanism underlying respiratory virus-induced acute lung injury (ALI) pulmonary fibrosis (PF) has not been fully elucidated. Here, cascade of monocyte-derived macrophages to influenza A virus infection is monitored on an optimized human alveolus chip reveal role in development ALI PF. We find that viral causes damage alveolar air–liquid barrier release inflammatory cytokines, which induce M0 gather polarize M1 phenotype at damaged site through recruitment, adhesion, migration, activation, leading ALI. Afterward, into M2 phenotype, then transform myofibroblasts, followed by enhanced secretion various anti-inflammatory cytokines profibrotic promote Our study provides insight pathogenesis PF, will assist therapeutic strategies drugs for treating other infections.
Язык: Английский
Процитировано
1
Vaccines, Год журнала: 2024, Номер 12(4), С. 420 - 420
Опубликована: Апрель 16, 2024
Patients with cancer can be immunocompromised because of their disease and/or due to anticancer therapy. In this population, severe influenza virus infections are associated an elevated risk morbidity and mortality. Influenza vaccination is therefore highly recommended in patients, including those receiving However, coverage remains far below the target for vulnerable subjects. Six specialists oncology, hematology, immunology, public health/vaccinology convened objective developing strategies, based on evidence clinical experience, improving patients. This viewpoint provides overview current recommendations discusses barriers coverage, presents strategies overcoming said barriers. New immunization issues raised by COVID-19 pandemic also addressed. Future directions include education vaccination, providing media accurate information, knowledge among healthcare professionals, access vaccines co-administration vaccines, increased collaboration between oncologists other health accessibility digital registries specialists, shared information platforms, promoting campaigns systems support scientific societies.
Язык: Английский
Процитировано
0
Vaccine, Год журнала: 2024, Номер 42(20), С. 125972 - 125972
Опубликована: Май 24, 2024
Pneumonia is one of the main contributors to non-cancer mortality among patients with head and neck cancer (HNC). This study aimed determine vaccine uptake for pneumococcal polysaccharide conjugate vaccines, quadrivalent influenza mRNA COVID-19 vaccines before after an HNC diagnosis. Furthermore, investigated timing vaccination a
Язык: Английский
Процитировано
0